129 related articles for article (PubMed ID: 5047748)
1. Potential antitumor agents. Some 1,6-disubstituted galactitol and mannitol derivatives.
Acton EM; Keyanpour-Rad M; Christensen JE; Tong HH; Kwok RP; Goodman L
Carbohydr Res; 1972 May; 22(2):477-86. PubMed ID: 5047748
[No Abstract] [Full Text] [Related]
2. The effect of dibromodulcitol (NSC 104800) on intravenously induced cytemia of rats.
Németh L
Neoplasma; 1971; 18(5):533-7. PubMed ID: 5119525
[No Abstract] [Full Text] [Related]
3. Clinical pharmacology of dibromohexitols.
Eckhardt S
Haematologica; 1972 Apr; 57(11):722-31. PubMed ID: 4200307
[No Abstract] [Full Text] [Related]
4. Synthesis of new sugar derivatives having potential anti-tumour activity. XVI. Derivatives of D-mannitol which are differently substituted at C-1 and C-6.
Kuszmann J; Vargha L
Carbohydr Res; 1971 Apr; 17(2):309-18. PubMed ID: 5150893
[No Abstract] [Full Text] [Related]
5. Aryl-2-halogenoalkylamines. XXII. Derivatives of phenoxyacetic acid: synthesis and antineoplastic activities.
Artico M; Ross WC
Biochem Pharmacol; 1968 Jun; 17(6):873-82. PubMed ID: 5661350
[No Abstract] [Full Text] [Related]
6. Aryl-2-halogenoalkylamines. 23. Derivatives of oxanilic acid and salicylic acid: synthesis and antineoplastic activities.
Artico M; Ross WC
Biochem Pharmacol; 1968 Jun; 17(6):883-91. PubMed ID: 5661351
[No Abstract] [Full Text] [Related]
7. Aryl-2-halogenoalkylamines. XXIV. Derivatives of o-, m- and p-aminophenol: synthesis and antineoplastic activities.
Artico M; Ross WC
Biochem Pharmacol; 1968 Jun; 17(6):893-8. PubMed ID: 5661352
[No Abstract] [Full Text] [Related]
8. 1,2-anhydro-6-O-methanesulphonyl-D-mannitol.
Tisdale MJ
Carbohydr Res; 1971 Aug; 19(1):117-8. PubMed ID: 5151525
[No Abstract] [Full Text] [Related]
9. Synthesis of new sugar derivatives having potential antitumour activity. XVII. Synthesis and oxidation of 1,4:3,6-bis(thioanhydro)-D-iditol and its 2,5-diacetate.
Kuszmann J; Sohár P
Carbohydr Res; 1972 Jan; 21(1):19-27. PubMed ID: 5044140
[No Abstract] [Full Text] [Related]
10. Some antitumor agents derived from benzaldehyde nitrogen mustards.
Florvall L
Acta Pharm Suec; 1970 Apr; 7(2):87-104. PubMed ID: 5421623
[No Abstract] [Full Text] [Related]
11. Dibromodulcitol (NSC-104800)--clinical brochure.
Carter SK
Cancer Chemother Rep 3; 1968 Dec; 1(1):165-77. PubMed ID: 4989813
[No Abstract] [Full Text] [Related]
12. Potential anticancer agents. Nitrogen mustards of aminophenylthiazoles.
Modi JD; Sabnis SS; Deliwala CV
J Med Chem; 1971 Sep; 14(9):887-8. PubMed ID: 5140020
[No Abstract] [Full Text] [Related]
13. The effect of cytostatic hexitol derivatives on haematopoietic stem cells, the L1210 leukaemia and C22LR osteosarcoma.
Fuzy M; Lelieveld P; Van Putten LM
Eur J Cancer (1965); 1975 Mar; 11(3):169-73. PubMed ID: 165939
[No Abstract] [Full Text] [Related]
14. Tumor inhibitors. 3. Identification and synthesis of an oncolytic hydrocarbon from American coneflower roots.
Voaden DJ; Jacobson M
J Med Chem; 1972 Jun; 15(6):619-23. PubMed ID: 5030929
[No Abstract] [Full Text] [Related]
15. The formation of 1,6-thioanhydrohexitols from the 1,6-di-O-mesyl derivatives of D-mannitol and galactitol.
Jarman M; Griggs LJ
Carbohydr Res; 1975 Nov; 44(2):317-20. PubMed ID: 1203909
[No Abstract] [Full Text] [Related]
16. Initial clinical trial of dibromodulcitol (NSC-104800) in patients with advanced cancer.
Keyes JW; Selawry OS; Hansen HH
Cancer Chemother Rep; 1971 Dec; 55(5):583-9. PubMed ID: 5003621
[No Abstract] [Full Text] [Related]
17. Structure-activity relationships of ethylenimines. 8. Optically active methyl-substituted ethylenimines.
Bottini AT; Dev V; Dowden BF; Gandolfi AJ
J Med Chem; 1969 Mar; 12(2):332-3. PubMed ID: 5783614
[No Abstract] [Full Text] [Related]
18. Carcinostatic sulfonic acid esters of butyne- and butane-1,4-diols.
Earl RA; Harmon RE
J Med Chem; 1966 Sep; 9(5):776-8. PubMed ID: 5969056
[No Abstract] [Full Text] [Related]
19. Irreversible enzyme inhibitors. CIX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. 3.
Baker BR; Lourens GJ
J Med Chem; 1968 Jan; 11(1):26-33. PubMed ID: 5237171
[No Abstract] [Full Text] [Related]
20. [Clinical experiences with Dibromdulcitol (DBD) in the treatment of cancer].
Nyiredy G; Gévai E
Bronches; 1971; 21(2):202-6. PubMed ID: 5126170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
